MASINI, CHIARA
MASINI, CHIARA
STUDI STORICI
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin
2022-01-01 Iacovelli, R; Ciccarese, C; Brunelli, M; Battelli, N; Buttigliero, C; Caserta, C; Buti, S; Santini, D; Carella, C; Galli, L; Verri, E; Ermacora, P; Merler, S; Masini, C; De Vivo, R; Milesi, L; Spina, F; Rizzo, M; Sperduti, I; Fornarini, G; Tortora, G
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort
2021-01-01 Fornarini, G; Rebuzzi, S E; Banna, G L; Calabrò, F; Scandurra, G; De Giorgi, U; Masini, C; Baldessari, C; Naglieri, E; Caserta, C; Manacorda, S; Maruzzo, M; Milella, M; Buttigliero, C; Tambaro, R; Ermacora, P; Morelli, F; Nolè, F; Astolfi, C; Sternberg, C N
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
2020-01-01 Caffo O.; Zagonel V.; Baldessari C.; Berruti A.; Bortolus R.; Buti S.; Ceresoli G.L.; Donini M.; Ermacora P.; Fornarini G.; Fratino L.; Masini C.; Massari F.; Mosca A.; Mucciarini C.; Procopio G.; Tucci M.; Verri E.; Zucali P.; Buttigliero C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin | 2022 | Iacovelli, R; Ciccarese, C; Brunelli, M; Battelli, N; Buttigliero, C; Caserta, C; Buti, S; Santini, D; Carella, C; Galli, L; Verri, E; Ermacora, P; Merler, S; Masini, C; De Vivo, R; Milesi, L; Spina, F; Rizzo, M; Sperduti, I; Fornarini, G; Tortora, G | |
| Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort | 2021 | Fornarini, G; Rebuzzi, S E; Banna, G L; Calabrò, F; Scandurra, G; De Giorgi, U; Masini, C; Baldessari, C; Naglieri, E; Caserta, C; Manacorda, S; Maruzzo, M; Milella, M; Buttigliero, C; Tambaro, R; Ermacora, P; Morelli, F; Nolè, F; Astolfi, C; Sternberg, C N | |
| On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 | 2020 | Caffo O.; Zagonel V.; Baldessari C.; Berruti A.; Bortolus R.; Buti S.; Ceresoli G.L.; Donini M.; Ermacora P.; Fornarini G.; Fratino L.; Masini C.; Massari F.; Mosca A.; Mucciarini C.; Procopio G.; Tucci M.; Verri E.; Zucali P.; Buttigliero C. |